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ABSTRACT
Background: Intracytoplasmic sperm injection (ICSI) involves mechanical transfer of a single sperm cell into ooplasm. 
A new application has been recently found for ICSI, the production of transgenic animals. Since the birth of ‘‘Dolly’’, the 
first adult somatic cloned mammal, viable offspring has been produced by nuclear transfer in many species including cat-
tle.  The present review briefly summarizes our experience with ICSI and somatic cell nuclear transfer mainly to produce 
transgenic embryos, as well as for the generation of new micromanipulation technique.
Review: We have evaluated different factors that affect SCNT and transgenesis including the chemical activator, the 
transfection event and the effect of recloning. Also, we included a brief description of the ICSI technique, which we used 
in five different species, examining its potential to produce transgenic embryos. Finally different strategies to produce 
transgenic animals were analyzed: ICSI- mediated gen transfer (ICSI-MGT), Injection of cumulus cell and ooplasmic 
vesicle incubated for 5 min with the transgene or injection of the plasmid alone. All of them were very efficient in exo-
genous DNA expression at embryo stages but resulted in mosaic embryos.  We demonstrated that “ICSI-MGT” assisted 
by chemical activation is the only treatment of sperm mediated gen transfer capable to generated transgenic embryos in 
ovine.  Besides, after ICSI-MGT, it is possible to obtain enhanced green fluorescent protein (EGFP)-expressing embryos 
in five diferent species: ovine, porcine, feline, bovine and equine. Our studies also established for the first time that short 
term transgene co-incubation with somatic cells can produce transgene-expressing mammalian SCNT embryos, and also 
that parthenogenic, eDNA- expressing embryos can be obtained by injection of vesicles or eDNA alone. Moreover, eDNA-
-expressing embryos can be also obtained by cytoplasmic injection of vesicles in IVF zygotes, simplifying the traditional 
IVF pronuclear injection technique. We tried a further simplification of the technique in bovine oocytes and zygotes, by 
intracytoplasmically injecting them with eDNA-liposomes complexes. Approximately 70% of the cleaved embryos and 
50% of the blastocysts expressed EGFP, when egfp–liposome was injected 16 h post-fertilization. Different approaches 
were assayed to reverse the mosaicism including a novel technique of gamete cloning. Our first approach consisted of the 
production of transgenic IVF embryos by vesicle microinjection to generate transgenic blastomeres to be used as donor 
cells for cloning. A high efficiency in mosaicism reversal and multiplication of transgenic embryos was attaineded. Other 
technique assayed was the separation of transgenic blastomeres followed by the aggregation of two-cell fused embryos or 
by the asynchronous younger blastomere successfully multiplied transgenic embryos, and theoretically reduces mosaicism 
rates in future offspring [15]. This technology can also be used to multiply embryos from animals with high genetic value. 
We demonstrated that a sperm and oocyte can be efficiently cloned. Green haploid androgenic blastomeres produced with 
the injection of a single sperm by egfp ICSI-MGT could be used to fertilized oocytes resulting in several homogeneous 
expressing embryos. This approach shows great potential because it allows for determination of the sex of the sperm nucleus 
prior to fertilization. It is also possible to clone previously transfected oocytes followed by the reconstruction of biparental 
bovine embryos to generate homogeneous transgene-expressing embryos. This review summarizes recent experiments in 
micromanipulation and gene transfer in domestic animals. The objective is not to exhaustedly describe the research done 
in this field but to present the promising methods recently developed or evaluated in our lab. 
Conclusion: Significant advancements have been made in the course of the recent years in micromanipulation and trans-
genesis techniques.  In our lab we have been evaluating ICSI and Nuclear transfer mainly to produce transgenic embryos. 
We used also transgensis to apply or developed new micromanipulation technique in domestic animals linke sperm and 
oocyte cloning.
Keywords: Micromanipulation, transgenesis, ICSI, cloning, nuclear transfer.
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II. CLONING BY NUCLEAR TRANSFER
Cloning by somatic cell nuclear transfer has 
raised enormous interest; mainly it has made possible 
the propagation of elite domestic animals and the 
enginering of transgenic animals for agricultural and 
biomedical purposes. Briefly, nuclear transfer (NT) 
involves the enucleation of a recipient oocyte, follo-
wed by the transfer of a donor cell to the perivitelline 
space in close apposition of the recipient cytoplast, 
and their fusion. Development is induced artificially 
by chemical or physical activation. Production of 
cloned offspring by somatic cell nuclear transfer has 
been successfully attained in sheep [5,50,53], goats 
[1] and cows [8,17,50].
There are several factors that influence the 
results of NT including the methods of enucleation 
[26], fusion, activation and donor-recipient cell cycle 
synchrony. High efficiencies in enucleation of recipient 
oocytes have been achieved using DNA specific vital 
dyes to visualize chromatin [51,41]. Fusion of the 
donor cell with the recipient oocyte depends on the 
accuracy of cell alignment in the pulse field, contact 
of the donor cell with the recipient oocyte and size of 
the donor cells [9]. Nucleus can also be injected [6]. 
Activation of NT reconstructed embryos has been 
refined and rates of development into blastocysts are 
equivalent to in vitro fertilized oocytes [21].
Successful development of NT embryos has 
been accomplished using mature oocytes [52], zygote 
[24] and cleavage-stage embryos [44] as recipient cyto-
plast. However, this is dependent on the source of the 
donor nucleus. Compatibility of the cell cycle between 
the recipient cytoplasts and the donor cell is one of the 
important factors that influence development of NT 
embryos. Appropriate synchronization is necessary 
to preserve the ploidy of the reconstituted embryo. 
A problem with existing nuclear transfer syste-
ms is that the survival of cloned embryos and fetuses is 
low. One possible explanation is that the donor nucleus 
may not be competent to support normal development. 
Somatic cells have been programmed to differentiate 
into a particular cell; its nucleus is programmed to 
transcribe a specific set of RNAs that are translated 
into a set of proteins that results in the cell having all 
the characteristics of its type. After nuclear transfer 
the nuclei condense, and many proteins that bind to 
chromatin and regulate transcription must be released. 
Other proteins may bind at the time of activation to 
induce decondensation. Reconstructed embryos can 
also present errors in genomic imprinting. The modi-
fication or disruption of genomic imprinting in early 
development may cause genetic diseases. Embryo 
imprinting was evaluated by several authors and may 
represent a problem for embryo or fetal survival during 
reconstruction [14,33].
A new compound Dehydroleucodine (DhL) 
was evaluated as a chemical activator to produce SCNT 
reconstructed embryos [46]. Results showed that DhL 
induces pronuclear formation dynamics more simi-
lar to IVF than 6-dimethylaminopurine (6-DMAP). 
Blastocyst development was higher after activation 
with this new compound combined with Citochalasyn 
B. Moreover, all DhL treatments induced polyploidy 
rates lower than Ionomycin followed by 6-DMAP, but 
cloned blastocyst rates statistically similar [6].
One of the main applications of SCNT is the 
cloning of animals of genetic value. We assessed a new 
alternative cloning technique, previously described in 
the bovine [34], which consists of aggregating zone 
free genetically identical cloned embryos as a strategy 
to improve in vitro and in vivo embryo development 
in the equine. Embryo aggregation improved the qua-
lity of in vitro equine cloned embryos at day 7, and 
pregnancy rates were higher. The sizes of vesicles and 
embryos in vivo were normal for all groups, and in vitro 
development of aggregated embryos beyond day 7 re-
sulted in the highest embryo viability. Cloning equines 
by means of aggregation of two or three embryos does 
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not imply extra oocytes, and it is a good strategy to 
improve in vitro embryo development without altera-
tions in in vivo progress. The first living cloned foal 
obtained by this method was born from two aggregated 
embryos On August 4, 2010 [11].
III. CLONING BY NUCLEAR TRANSFER USING A 
TRANSFECTED CELL LINE
After nuclear transfer was developed, micro-
injec tion tended to be replaced by nuclear transfer 
using genetically modified somatic donor cells [39,8]. 
A cow capable of expressing human growth hormone 
(hGH) was delivered in South America in September 
of 2002. The hGH production in milk from this animal 
was evaluated and results were published by Salamone 
et al. [38] in 2006. It was demonstrated that hGH can 
be produced at a large scale in the milk of transgenic 
cows. Only about 15 animals would be necessary to 
meet the worldwide requirements of this protein for 
the treatment of dwarfism in GH deficient children 
[38]. However, nuclear transfer as was described pre-
viously using genetically modified somatic donor cells 
presents a low overall efficiency, explained partly by 
epigenetic reprogramming failure [36].
Although, cloning is one of the most powerful 
techniques available to generate transgenic animals, 
several additional problems appear during clone pro-
duction. For example, different transfection events of 
the same somatic cell line can affect embryo and/or 
fetal survival. In one experiment performed for a Bio-
technology company, a fetal cell line was established 
from a 75-day-old Jersey female fetus, which was used 
as control and was also transfected 3 times with the 
same protocol. They were named Transfection 1, 2, 
and 3. Genetically modified cells were produced and 
isolated after selection with geneticin for 10–15 days 
following liposome transfection with a DNA construct 
containing a selectable neomycin resistance gene.
Results of embryo and fetal development are 
presented in table 1. One birth was obtained from the 
control. Four and 7 births were obtained from Trans-
fections 1 and 3, respectively. Although Transfection 2 
Treatment n Blastocyst (%) Implanted Recipients Preg. 30d (%) Birth
Control 197 122 (62) 33 (18) 4 1
Transfection 1 130 106 (82) 28 (22) 5 4
Transfection 2 137 96 (70) 34 (24) 0 0
Transfection 3 470 282 (60) 71 (15) 12 7
Table 1. Effect off different transfection events on same line in embryo and fetal survival. 
had good in vitro development, this treatment did not 
produce any pregnancies. This fact demonstrated that 
the transfection event provides an additional source 
of variability in obtaining live transgenic animals. 
Our results pointed out the necessity to monitor fetal 
survival by ultrasonography in order to detect any de-
ficiencies in development introduced by transfection 
as soon as possible.
In a large scale cloning program destined to 
obtain transgenic animals, it is very important to pro-
duce well-characterized transgene integration and gene 
expression. However, after non-homologous transfec-
tions a wide variety of transgene copy numbers are in-
troduced in different chromosome locations. Recloning 
a selected first-generation of transgenic calves offers 
the opportunity to increase the homogeneity among 
transgenic animals. Calf recloning was performed in 
an experiment (n= 1739 cloning procedure) in which 
the survival rate was evaluated after a second round of 
cloning from transgenic umbilical cord and ear calf fi-
broblast cell cultures. Seven births were obtained from 
the original fetal cell line, one birth was obtained from 
recloned umbilical cord cells and two calves from re-
cloned ear fibroblasts.  Development to blastocysts was 
different between transfected fetal fibroblasts and both 
recloned treatment groups. Differences were observed 
in pregnancy rates between blastocysts generated by 
the different sources of donor cells. Although it results 
in lower blastocyst production, our results suggest that 
recloning provides an additional method to obtain 
Percentages within columns with different superscripts are different (P < 0.05)
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transgenic animals, where fibroblasts from umbilical 
cord tissue could give better results for recloning than 
those obtained from young calf ear cells.
IV. INTRACYTOPLASMIC SPERM INJECTION (ICSI)
ICSI has been used in humans and mice 
[28,18]. In these species, sperm cell injection causes 
oocyte activation [27]. However, after ICSI most do-
mestic animals do not develop appropriately [23,22]. 
Chemical activation protocols for ICSI frequently 
use ionomycin, a calcium ionophore, followed by 3 
h of incubation previous to 6-DMAP treatment [35]. 
Recently, we produced a high rate of ICSI blastocysts 
in a domestic cat without chemical assisted activa-
tion, simplifying the procedure, and allowing for its 
application in the wild cat [25]. Most groups perform 
ICSI using a piezo-drill, but we recently obtained good 
blastocyst rates using chemical activation protocols, 
producing a live lamb Fig. 2 [31]. In equines this te-
chnique has great potential, because although oocytes 
can be recovered in vivo via ultrasound guided trans-
vaginal aspiration, they are impossible to fertilize by 
regular in vitro protocols. ICSI appears to bypass this 
problem and we recently generated good blastocyst 
rates in the equine. 
V. ICSI MEDIATED GENE TRANSFER
Several authors published techniques alter-
native to somatic cell nuclear transfer and pronuclear 
microinjection to obtain transgenic embryos and 
offspring including: Laparoscopic Insemination (LI) 
[19], In Vitro Fertilization (IVF) [20] and ICSI [32]. 
By LI and IVF, the possibility of generating transgenic 
animals is simple. However the use of these techni-
ques has been in substantial debate [20,4]. On the 
other hand, ICSI is an efficient technique to produce 
offspring in the murine [32]. 
One of the limitations of ICSI-mediated gene 
transfer is that it results in a high frequency of mosaic 
expression of the transgene. A possible explanation for 
this is that the transgene is not integrated in the embryo 
genome before the first cell divisions [40,32,43,16]. 
Moreover, the transgene could remain extra-chromo-
somal and be lost during successive mitotic divisions, 
as was already shown in two previous reports [7].
In one experiment, we used “ICSI-MGT” 
assisted by chemical activation in five species, ovine, 
porcine, feline, bovine and equine, demonstrating that 
it is possible to obtain enhanced green fluorescent 
protein (EGFP)-expressing embryos in all of them. The 
spermatozoa of the five species were coincubated with 
pCX-EGFP plasmid and injected into the MII oocyte. 
The chemical activation protocol was ionomycin 
followed 3 hours later by 3 hours of treatment with 
6-DMAP. We detected high proportions of the fluo-
rescent EGFP embryos in all five species (23 to 60%) 
at day four and produced green blastocysts in bovine, 
ovine and cat [30]. 
In cattle, ICSI- mediated gene transfer was not 
evaluated until a report by Pereyra et al. [30] in 2008. 
The main reason for this is the poor outcome after 
conventional ICSI in this species. In another study 
we looked at the best conditions for intracytoplasmic 
ICSI-MGT in cattle. Various aspects of fertilization 
and embryonic development were assessed after five 
activation treatments. Spermatozoa were co-incubated 
with pCX-EGFP plasmid and injected into metaphase 
II oocytes, which were then treated with ionomycin 
(Io) before further activation with the following agents: 
6-DMAP (Io-DMAP), additional Io plus 6-DMAP 
(2Io-DMAP), Io alone (2Io), ethanol (Io-EtOH), or 
strontium chloride (Io-SrCl2). Fertilization rates at 16 
h after ICSI, presence of a condensed spermatozoon 
head on Day 4, and blastocyst and EGFP expression 
rates on Day 7 were evaluated. Fertilization rates did 
not differ significantly among treatments. All (100%) 
of EGFP-positive embryos resulted from ICSI fertiliza-
tion, whereas at least 60% of EGFP-negative embryos 
had a condensed sperm head. Blastocyst rates after 
2Io-DMAP were not significantly different from Io-
-DMAP or Io-EtOH, but they were higher than 2Io or 
Io-SrCl2 treatments (25.9, 18.7, 14.7, 9.4, and 10.9% 
respectively). In bovine, ICSI-MGT proved to be a po-
werful technique because over 80% of the blastocysts 
expressed EGFP protein [2]. We evaluated LI, IVF 
and ICSI to produce egfp-expressing ovine embryos, 
using spermatozoa previously exposed to pCX-EGFP 
plasmid. High cleavage and morulae/blastocysts rates 
were obtained with LI and IVF, but no egfp-expressing 
embryos resulted. In contrast, 91.6% egfp-expressing 
morulae and blastocysts were generated by ICSI [29].
VI. GENE TRANSFER BY NUCLEAR MICROINJECTION
The first method reported to produce transge-
nic animals was the microinjection of foreign DNA 
into the male pronuclei of zygotes [12]. Trans gene sis 
by microinjection is still used mainly for research 
purposes in mice. This procedure has proven to be 
efficient in species such as rabbits, sheep and pigs 
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[13], but it is quite dependent on proper male pro nuclei 
visualization and in some species, like the bovi ne, the 
efficiency is very low [10].
VII. GENE TRANSFER BY CYTOPLASMIC 
MICROINJECTION
Based in our results with ICSI, we tested if the 
sperm cell was a special cell to transfer the transgene, 
or if other cell types could also act as vectors. Surpri-
singly, when we injected cumulus cells or oolemma 
vesicles previously incubated with eDNA, and naked 
eDNA into the cytoplasm of MII oocytes we observed 
expression of eDNA [29]. Using confocal microscopy 
interaction, an interaction of FITC- labeled eDNA 
with cumulus cells and vesicles was demonstrated. 
In contrast, oocytes injected with DNA alone did not 
show signs of transgene accumulation, and their eDNA 
expression rates were lower. In a further experiment, 
we evaluated if transgene-expressing embryos could 
be produced by means of vesicle injection followed by 
IVF. Preliminary FISH analysis indicated detectable 
integration events in 1/5 of SCNT blastocysts treated. 
Our studies demonstrate for the first time that short 
term transgene co-incubation with somatic cells can 
produce transgene-expressing mammalian SCNT em-
bryos, and also that parthenogenic, eDNA- expressing 
embryos can be obtained by injection of vesicles or 
eDNA alone. Moreover, eDNA-expressing embryos 
can be also obtained by cytoplasmic injection of ve-
sicles in IVF zygotes, simplifying the traditional IVF 
pronuclear injection technique.
In other experiments different approaches were 
studied to improve transgenesis efficiency and to avoid 
mosaic expression patterns of transgene-expressing 
embryos. Circular and linear plasmid structures and 
cell cycle inhibitors (6-DMAP, and DhL) were tested 
to this aim [3]. Egfp expression was higher for linear 
than circular pCX-EGFP, and green blastocyst rates 
were higher for the groups inoculated with linear 
transgene incubated with vesicles than for free linear 
plasmid alone. FISH analysis showed integration 
evidence in green embryos. The cell cycle inhibitor 
6-DMAP increased phosphorylated histone H2AX 
foci area, which mark DNA double stranded breaks 
and reduced mosaic expression. 
We tried a further simplification of the techniqe 
in bovine oocytes and zygotes, by intracytoplasmically 
injecting them with eDNA-liposomes complexes. Ap-
proximately 70% of the cleaved embryos and 50% of 
the blastocysts expressed EGFP, when egfp–liposome 
was injected 16 h post-fertilization [48].
The percentage of integration of all these me-
thods remains to be confirmed. 
VIII. DIFFERENT APPROACHES FOR EMBRYO 
MULTIPLICATION AND MOSAICISM REVERSION
Our first approach consisted of the production 
of transgenic IVF embryos by vesicle microinjection 
to generate transgenic blastomeres to be used as do-
nor cells for cloning. A high efficiency in mosaicism 
reversal and multiplication of transgenic embryos was 
attaineded [3]. 
The separation of transgenic blastomeres 
followed by the aggregation of two-cell fused embryos 
or by the asynchronous younger blastomere success-
fully multiplied transgenic embryos, and theoretically 
reduces mosaicism rates in future offspring [15]. This 
technology can also be used to multiply embryos from 
animals with high genetic value.
Another technique that we assessed was 
reducing mosaicism through gamete cloning. We de-
monstrated that a sperm and oocyte can be efficiently 
cloned [47,45,49]. Green haploid androgenic blasto-
meres produced with the injection of a single sperm 
by egfp ICSI-MGT could be used to fertilized oocytes 
resulting in several homogeneous expressing embryos. 
This approach shows great potential because it allows 
for determination of the sex of the sperm nucleus prior 
to fertilization. It is also possible to clone previously 
transfected oocytes [49] followed by the reconstruction 
of biparental bovine embryos to generate homoge-
neous transgene-expressing embryos. This opens the 
possibility for sperm or oocyte genome cloning by 
multiplying the gamete in a haploid line. This would 
have the potential to generate an unlimited number of 
biparental embryos by combining these haploid cells 
with haploid hemizygotes of the opposite sex. 
The applications of these technologies are 
subject to our capacity for imagination and innovation. 
Animals that we have generated with some of these 
methodologies (Figure 1, 2 and 3) have formed a 
kind of postcard into the future that demonstrates the 
possibility to use these technologies in our countries. 
IX. CONCLUSIONS
Significant advancements have been made in 
the course of the recent years in micromanipulation 
and transgenesis techniques.  In our lab we have been 
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Figure 1. BS Ñandubay Bicentenario cloned horse produce in 2010.
Figure 2. Pampa dynasty: clones produced from a Growth Hormone 
transfected cell line in 2002.
Figure 3. Esperanza lamb generated by ICSI produced in 2008.
evaluating ICSI and Nuclear transfer mainly 
to produce transgenic embryos. We used also 
transgenesis developed to mark with flurorecence 
protein expression and develop new microma-
nipulation technique in domestic animals like 
gamete cloning. All these approach has enormous 
potential for use in livestock production. One of the 
main applications is introducing genes to modify the 
genome for biomedicine or agriculture.
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